Albete, Zyvonna Red S.

HRN: 21-63-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/01/2024
08/04/2024
PO
3 Ml
Q12hrs
Urinary Tract Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: